When An Expensive Stock Is Not Expensive At All

ARM Holdings Plc (LON:ARM) and Ted Baker plc (LON:TED) will help you understand why trading multiples do not always tell the full story, argues Alessandro Pasetti.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are certain stocks that investors consider to be expensive simply because they trade high based on trading metrics such as price-to-earnings ratio, enterprise value (EV) to earnings before interest, taxes, depreciation and amortisation (EBITDA), and EV to revenues.

But take ARM (LSE: ARM), a British chip designer, whose stock: a) trades at its one-year high; b) has risen 30% since mid-October; c) has been recently added to Citi’s focus list and Goldman’s conviction buy list (this is not necessarily a good sign, as others will have noticed!); d) and trades at 50x forward earnings, and 18x EV/revenue. 

Or consider Ted Baker (LSE: TED)just a British retailer, whose shares have been on my wish list since they traded at around £19 in June, and now change hands above £23. The implied pre-tax return on your investment, excluding dividends, would be about 20% in half a year. Ted trades at almost 30x projected earnings, and 3x/EV revenue.  

The shares of these two companies — which trade at higher multiples than the FTSE‘s — as well as those of other apparently “expensive” candidates should deserve attention, even in this market. But how do you identify them?

In short, it goes down to size, fundamentals (P&L, balance sheet, cash flow statements), track record and management.

Growth/Free Cash Flow/Size

Both ARM and Ted have grown their businesses a lot over the years, but they are still relatively small players in their respective markets. 

As I noted in June 2014, Ted’s revenues and operating profit (Ebit) had doubled to £320m and £40.6m, respectively, in the four previous years, which testifies to the management’s skills. If current expansion plans are successful, which I think is likely, revenues and Ebit will continue to grow, yielding a significant rise in earnings and dividends per share.

ARM isn’t too different, really, having recorded an impressive operating performance over the years. Its management team knows how business is done and how to manage expectations. Of course, both companies present healthy free-cash-flow profiles. 

Balance Sheet  

ARM and Ted have strong balance sheets and could easily raise more debt — higher leverage would boost return on equity. Short-term volatility shouldn’t be ruled out, but that’s an obvious risk for all entities that must report on a quarterly basis. ARM, in particular, could benefit from favourable exchange rates movements. 

Virtually debt-free, both companies could also attract takeover bids. Ted Baker is an ideal target for private equity, which could lever up Ted’s balance sheet and deliver terrific returns if its strategy is properly implemented abroad. ARM has been often rumored to be a target for Intel, and we’ll see how that goes. This is not the main reason why investors should add these two stocks to their portfolios, but it’s one element I like. 

Expensive Stuff

Expensive stocks, for instance, are those of Diageo (LSE: DGE) and SABMiller (LSE: SAB), in my view. In recent times both companies have struggled to grow revenue and Ebit, and operate in an industry that has been in restructuring mode for years. Emerging-market exposure adds risk, too. 

Diageo and SAB are market leaders, so any tie-up would be difficult to execute, but the shares of both price in takeover premiums. Not only their shares trade high based on their relative valuations — about 20x earnings for Diageo, and 22x for SAB, on a forward basis — but their balance sheets also carry billions of debt, which is manageable overall, but gives them little room for action with regard to shareholder friendly-activity. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has recommended ARM Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman holding up three fingers
Investing Articles

3 stunning FTSE 100 shares I plan to buy in October 

Our writer identifies three stocks on the FTSE 100 he feels would add the variety of growth, income and stability…

Read more »

Investing Articles

With a 6% dividend, is this company a passive income no-brainer?

Dividend paying companies can be a game changer for building a passive income, but is this company the answer? Gordon…

Read more »

Investing Articles

2 value shares I’d happily snap up in a heartbeat

These two value shares look great value for money, and both possess their own unique offering with bullish traits our…

Read more »

Investing Articles

Up 13% in 2024, is the Aviva share price just getting started?

The Aviva share price has had a great 2024 to date, but is there more to come from this insurance…

Read more »

Growth Shares

This FTSE 250 stock fell 15% yesterday. Here’s why I want to buy the dip

Jon Smith talks through the negative news that caused a FTSE 250 stock to fall yesterday but flags up why…

Read more »

Investing Articles

1 under the radar stock I’d buy for my Stocks and Shares ISA

This Fool is looking for good dividend stocks to buy for her Stocks and Shares ISA and earmarks this investment…

Read more »

Investing Articles

This company might even beat the Amazon share price over the next few years

The Amazon share price is pretty synonymous with e-commerce investments, but I think there's a more appealing company out there.

Read more »

Investing Articles

1 growth stock that could skyrocket over the next 10 years

This investor is excited about the transformational potential of one growth stock that he's been eyeing up for his portfolio.

Read more »